Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Effect of Vitamin E Supplementation on Serum Aminotransferases in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis
Stamatina Vogli, Androniki Naska, Γεώργιος Μαρίνος, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3733-3733
Open Access | Times Cited: 22

Showing 22 citing articles:

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond
Allison Soto, Colby Spongberg, Alessandro Martinino, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 397-397
Open Access | Times Cited: 22
Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024)
Jian‐Gao Fan, Xiaoyuan Xu, Rui-Xu Yang, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 16
Role of Vitamin-E as a Vital Nutrient in Health and Diseases
Ghizal Fatima, Andrej Džupina, Abbas Ali Mahdi, et al.
Indian Journal of Clinical Biochemistry (2025)
Closed Access | Times Cited: 2
Adherence to an antioxidant diet and lifestyle is associated with reduced risk of cardiovascular disease and mortality among adults with nonalcoholic fatty liver disease: evidence from NHANES 1999–2018
Yingzi Li, Yipin Liu
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 12
Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
Mengyao Yan, Shuli Man, Long Ma, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 620-648
Open Access | Times Cited: 7
Vitamin E improves serum markers and histology in adults with metabolic dysfunction‐associated steatotic liver disease: Systematic review and meta‐analysis
N. Chee, Ram Prasad Sinnanaidu, Wah‐Kheong Chan
Journal of Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 6
Vitamin E for people with non-alcoholic fatty liver disease
Hong-Zhu Wen, Hongyong Deng, Lili Yang, et al.
Cochrane library (2024) Vol. 2024, Iss. 10
Closed Access | Times Cited: 5
Marine natural products as an important source of bioactive substances for non-alcoholic fatty liver disease management
Menglei Shi, Sisi Chen, Feng Yuan, et al.
Frontiers in Marine Science (2025) Vol. 11
Open Access
Mitochondrial Dysfunction as a Pathogenesis and Therapeutic Strategy for Metabolic-Dysfunction-Associated Steatotic Liver Disease
Xiangqiong Li, Wenling Chen, Zhuangzhuang Jia, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4256-4256
Open Access
ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease
Ashwani K. Singal, Robert J. Wong, Srinivasan Dasarathy, et al.
The American Journal of Gastroenterology (2025) Vol. 120, Iss. 5, pp. 950-972
Closed Access
Drug treatment for MASLD: Progress and direction
Da Zhou, Jian‐Gao Fan
Chinese Medical Journal (2024)
Open Access | Times Cited: 3
Targeting Metabolism: Innovative Therapies for MASLD Unveiled
Weixin Wang, Xin Gao, Wei Niu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4077-4077
Open Access
Association between composite dietary antioxidant index and fatty liver index among US adults
Meng Zheng, Chaochen Li, Jia Fu, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 2
Mechanisms of Vitamins Inhibiting Ferroptosis
Meng Zhang, Xin Chen, Yumei Zhang
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1571-1571
Open Access | Times Cited: 1
A patient-centered approach to dietary supplements for patients with chronic liver disease
Jennifer C. Lai, Melinda Ring, Anand Dhruva, et al.
Hepatology Communications (2024) Vol. 8, Iss. 11
Open Access | Times Cited: 1
Investigation of the potential connections between NAFLD-associated Alzheimer's disease: bioinformatics analysis of shared genes
Indrajit Bhattacharya, Tanmoy Bhattacharya, Amrita Sahu, et al.
Research Square (Research Square) (2024)
Closed Access
Treatment of NAFLD: Diet, Physical Activity, and Potential Pharmacological Options
Justyna Śliz, Natalia Aleksandra Popławska, Marta Skorupska, et al.
Quality in Sport (2024) Vol. 16, pp. 52219-52219
Open Access
O papel da vitamina E no tratamento da doença hepática gordurosa não alcoólica
Lethicya Alves Sousa Carvalho, Luíza Araújo Castro, Brenda Miranda Aidar, et al.
Revista Eletrônica Acervo Médico (2024) Vol. 24, pp. e16258-e16258
Open Access
The Impact of Japanese Dietary Patterns on Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
Takafumi Sasada, Chikara Iino, Satoshi Sato, et al.
Nutrients (2024) Vol. 16, Iss. 17, pp. 2877-2877
Open Access
Cold-Pressed Aristotelia chilensis (Mol.) Stuntz Seed Oil Prevents Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) in a High-Fat-Diet-Induced Obesity Murine Model
Benjamín Claria, Alejandra Espinosa, Alicia Rodrı́guez, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1384-1384
Open Access
Impact of Dipeptidyl Peptidase-4 Inhibitors on Aminotransferases Levels in Patients with Type 2 Diabetes Mellitus with Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trial
Gang Ma, Song Zhang, Baozhong Yu
Current Therapeutic Research (2024) Vol. 102, pp. 100768-100768
Open Access
A systematic review of dietary and circulating carotenoids and liver disease
Bihuan Hu, Jing Sui, Ying Wang, et al.
Food & Function (2024) Vol. 15, Iss. 19, pp. 9813-9832
Closed Access
Artemisia capillaris Thunb. Water Extract Alleviates Metabolic Dysfunction-associated Steatotic Liver Disease Disease by Inhibiting miR-34a-5p to Activate Sirt1-mediated Hepatic Lipid Metabolism
Liang Meng, Xiao Xiao, Miao Chen, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119030-119030
Closed Access
Valorizing Agro‐Food Waste for Nutraceutical Development: Sustainable Approaches for Managing Metabolic Dysfunction‐Associated Steatotic Liver Disease and Related Co‐Morbidities
Laura Comi, Claudia Giglione, Fationa Tolaj, et al.
Food Frontiers (2024)
Open Access
Page 1

Scroll to top